Leap Therapeutics Inc (LPTX)
2.98
-0.02
(-0.50%)
USD |
NASDAQ |
Nov 14, 12:43
Leap Therapeutics Price: 2.98 for Nov. 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 3.25 | 3.610 | 2.95 | 2.995 | 450905.0 |
Nov 12, 2024 | 3.26 | 3.375 | 3.04 | 3.25 | 566275.0 |
Nov 11, 2024 | 3.22 | 3.422 | 3.21 | 3.27 | 154004.0 |
Nov 08, 2024 | 3.45 | 3.45 | 3.23 | 3.24 | 246830.0 |
Nov 07, 2024 | 3.72 | 3.820 | 3.450 | 3.47 | 233932.0 |
Nov 06, 2024 | 3.56 | 3.92 | 3.56 | 3.71 | 342215.0 |
Nov 05, 2024 | 3.68 | 3.708 | 3.48 | 3.55 | 153847.0 |
Nov 04, 2024 | 3.69 | 3.83 | 3.40 | 3.67 | 389992.0 |
Nov 01, 2024 | 3.71 | 3.96 | 3.70 | 3.74 | 211808.0 |
Oct 31, 2024 | 4.20 | 4.24 | 3.61 | 3.74 | 553770.0 |
Oct 30, 2024 | 4.71 | 4.79 | 4.06 | 4.17 | 569421.0 |
Oct 29, 2024 | 4.10 | 4.77 | 4.00 | 4.61 | 904971.0 |
Oct 28, 2024 | 3.68 | 4.25 | 3.61 | 4.15 | 885363.0 |
Oct 25, 2024 | 3.35 | 4.25 | 3.35 | 3.60 | 1.511M |
Oct 24, 2024 | 3.00 | 3.40 | 2.97 | 3.29 | 540989.0 |
Oct 23, 2024 | 3.01 | 3.15 | 2.80 | 3.06 | 225296.0 |
Oct 22, 2024 | 2.98 | 3.10 | 2.82 | 3.04 | 235890.0 |
Oct 21, 2024 | 2.68 | 3.00 | 2.53 | 2.98 | 370274.0 |
Oct 18, 2024 | 2.33 | 2.71 | 2.211 | 2.675 | 1.745M |
Oct 17, 2024 | 2.41 | 2.430 | 2.305 | 2.33 | 130573.0 |
Oct 16, 2024 | 2.29 | 2.42 | 2.27 | 2.40 | 206204.0 |
Oct 15, 2024 | 2.34 | 2.39 | 2.20 | 2.29 | 272472.0 |
Oct 14, 2024 | 2.31 | 2.45 | 2.31 | 2.34 | 75564.00 |
Oct 11, 2024 | 2.31 | 2.35 | 2.31 | 2.31 | 47125.00 |
Oct 10, 2024 | 2.33 | 2.408 | 2.302 | 2.33 | 49509.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.30
Minimum
Oct 02 2023
40.10
Maximum
Sep 30 2021
12.40
Average
12.00
Median
May 26 2022
Price Benchmarks
AIM ImmunoTech Inc | 0.2461 |
Perspective Therapeutics Inc | 9.05 |
Protalix BioTherapeutics Inc | 1.36 |
Electromed Inc | 28.50 |
Armata Pharmaceuticals Inc | 2.73 |
Price Related Metrics
PS Ratio | 59.69 |
Price to Book Value | 1.733 |
Earnings Yield | -58.39% |
Market Cap | 114.03M |